{
    "2021-02-26": [
        [
            {
                "time": "2021-02-16",
                "original_text": "Eli Lilly (LLY) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Mutations",
                        "Covid"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy",
                "features": {
                    "keywords": [
                        "U.S. Government",
                        "Purchase",
                        "Doses",
                        "Antibody Therapy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine",
                "features": {
                    "keywords": [
                        "Global COVID cases",
                        "FDA",
                        "J&J vaccine"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "Eli Lilly Signs $210 Million Deal With U.S. for Covid-19 Antibody Therapy",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Deal",
                        "Covid-19",
                        "Antibody Therapy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy",
                "features": {
                    "keywords": [
                        "US Government",
                        "Calls",
                        "Additional",
                        "Eli Lilly",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "What's Moving The Market Friday? US Stocks Near Flat, Euro, Asian Stocks Lower",
                "features": {
                    "keywords": [
                        "Moving The Market",
                        "US Stocks",
                        "Flat",
                        "Euro",
                        "Asian Stocks"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "global markets"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "UPDATE 2-U.S. to buy at least 100,000 doses of Lilly's COVID-19 antibody therapy",
                "features": {
                    "keywords": [
                        "U.S.",
                        "buy",
                        "doses",
                        "Lilly's",
                        "COVID-19",
                        "antibody therapy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "Eli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapy",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "U.S. government",
                        "agreed",
                        "buy",
                        "COVID",
                        "antibody therapy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19",
                "features": {
                    "keywords": [
                        "Lilly",
                        "announces",
                        "additional doses",
                        "neutralizing antibody therapy",
                        "U.S. government",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}